African Journal Of Biotechnology News
- Researchers find new molecule that controls pain sensitivity from UVB irradiation Thursday, July 7, 2011 @ 6:57AMResearchers at King's College London have found a molecule in the body which controls sensitivity to pain from UVB irradiation, identifying it as a new target for medicines to treat pain caused by other common inflammatory conditions such as arthritis.
- Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical studies for combating sleeping sickness Wednesday, June 29, 2011 @ 5:05AMAnacor Pharmaceuticals, the Drugs for Neglected Diseases initiative (DNDi), and SCYNEXIS Inc. today announced the successful completion of pre-clinical studies for the first new oral drug candidate discovered specifically to combat human African trypanosomiasis (HAT), also known as sleeping sickness.
- Eating more soluble fiber and engagement in moderate activity reduces belly fat Monday, June 27, 2011 @ 11:06AMAll fat is not created equal. Unsightly as it is, subcutaneous fat, the fat right under the skin, is not as dangerous to overall health as visceral fat, the fat deep in the belly surrounding vital organs.
- Soluble Fiber Strikes a Blow to Belly Fat Monday, June 27, 2011 @ 9:36AMAll fat is not created equal. Unsightly as it is, subcutaneous fat, the fat right under the skin, is not as dangerous to overall health as visceral fat, the fat deep in the belly surrounding vital organs.
- Cancer Statistics 2011 report finds not all segments of the population have benefitted equally Saturday, June 18, 2011 @ 4:24AMA steady reduction in overall cancer death rates translates to the avoidance of about 898,000 deaths from cancer between 1990 and 2007, according to the latest statistics from the American Cancer Society.
- Millennium reports results from two VELCADE based combination studies against multiple myeloma Wednesday, June 8, 2011 @ 4:05AMMillennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two studies of VELCADE (bortezomib) for Injection based combinations in patients with relapsed or refractory multiple myeloma (MM).
- Researcher to evaluate new approach for treatment of triple-negative breast cancer Saturday, June 4, 2011 @ 4:14AMA multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women.
- Cancer vaccine shows improved response rate in patients Friday, June 3, 2011 @ 8:29AMA vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson Cancer Center and Indiana University Health Goshen Center for Cancer Care.
- Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference Monday, May 30, 2011 @ 3:29AMAugurex Life Sciences Corp. today reported that in London at the European League Against Rheumatism Conference, leading arthritis researchers presented important data on Augurex's rheumatoid arthritis biomarker blood test and novel drug target.
- Taking prenatal vitamins early during pregnancy can reduce risk of having children with autism Thursday, May 26, 2011 @ 1:48AMWomen who reported not taking a daily prenatal vitamin immediately before and during the first month of pregnancy were nearly twice as likely to have a child with an autism spectrum disorder as women who did take the supplements - and the associated risk rose to seven times as great when combined with a high-risk genetic make-up, a study by researchers at the UC Davis MIND Institute has found.
- African Americans with SLE have higher antibody response to influenza vaccination: Study Friday, May 20, 2011 @ 11:34PMNew research shows that African Americans with systemic lupus erythematosus had a higher antibody response to influenza vaccination than European American patients.
- Diet quality, not quantity, can make a difference in risk for type 2 diabetes Friday, May 20, 2011 @ 7:34AMSmall differences in diet - even without weight loss - can significantly affect risk for diabetes, according to research from the University of Alabama at Birmingham published online May 18, 2011, by the American Journal of Clinical Nutrition.
- Last Smallpox Virus On Earth: Experts Debate Destroying It Friday, May 13, 2011 @ 3:40PMLONDON -- Smallpox, one of the world's deadliest diseases, eradicated three decades ago, is kept alive under tight security today in just two places – the United States and Russia.
- Countries debate destruction of last smallpox viruses Friday, May 13, 2011 @ 12:47PMSmallpox, one of the world's deadliest diseases, eradicated three decades ago, is kept alive under tight security today in just two places -- the United States and Russia.
- Decades after eradicating smallpox, countries mull whether to destroy last remaining viruses Friday, May 13, 2011 @ 10:46AMLONDON - Smallpox, one of the world's deadliest diseases, eradicated three decades ago, is kept alive under tight security today in just two places — the United States and Russia.
- Millennium presents three studies in relapsed multiple myeloma at IMW meeting Friday, May 6, 2011 @ 4:13AMMillennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.
- Scientists identify key enzyme that destroys lung tissue in TB Tuesday, April 26, 2011 @ 12:07AMScientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis, they report today in the Journal of Clinical Investigation. Drugs that inhibit this enzyme are already available, meaning that the finding could lead quickly to new treatments.
- Green Fields: Rastetter: Lower food costs by cutting travel distance Sunday, April 10, 2011 @ 4:09AMIowa agribusiness entrepreneur and Republican heavyweight Bruce Rastetter showed a bit of a green streak in a speech to the Rotary Club of Des Moines last week.
- Champions Biotechnology is now Champions Oncology Monday, April 4, 2011 @ 11:42AMChampions Biotechnology, Inc. announced today that it has changed its name to Champions Oncology, Inc.
- Sickle cell trait can cause sudden death in young African-American athletes Monday, April 4, 2011 @ 1:42AMThe sickle cell trait could be a cause-albeit rare-of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions, April 1-3, in New Orleans.
- Brazilian fossil linked to South Africa Monday, March 28, 2011 @ 8:47PMA 260 million-year-old fossil found in Brazil has been linked to a South African fossil found in the country in 1999. The find was published in the newest edition of the journal Science.
- Majority of men on ADT after prostatectomy gain weight during first year of therapy Friday, March 11, 2011 @ 5:53AMSeventy per cent of men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg, according to a paper in the March issue of the urology journal BJUI.
- FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD Friday, March 11, 2011 @ 4:38AMDiabetes and high blood pressure are the two leading causes of chronic kidney disease, a health problem that is growing at an alarming rate in the United States. There are 26 million Americans who have CKD, and millions more are at increased risk and may not even know it.
- Study Traces Human Origins To Southern Africa Tuesday, March 8, 2011 @ 10:26AMModern man may have evolved from the bushmen of Southern Africa, not from the eastern part of the continent as many experts suggest, claims a new study published Monday in the journal Proceedings of the National Academy of Sciences (PNAS). A team of experts from Stanford University, Santa Clara University, the University of California, Brown University, Cornell University, the Yale University ...
- FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment Thursday, February 24, 2011 @ 12:47AMBristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has approved the inclusion of data from two clinical studies in an update to the ONGLYZA U.S. Prescribing Information for adult type 2 diabetes patients.
- New fully human monoclonal antibodies to battle Chikungunya Wednesday, February 16, 2011 @ 11:12PMThe Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
- Unmet need for medical help to address sexual issues in breast, gynecologic cancer survivors Tuesday, February 15, 2011 @ 12:31AMMany women who survive breast and gynecologic cancers want medical help for their sexual issues, but most do not get it. A survey of hundreds of cancer survivors, published online in the journal Cancer, confirms that more than forty percent want medical attention for their sexual health needs.
- Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors Thursday, February 10, 2011 @ 5:16AMThe New England Journal of Medicine (NEJM) published a study today that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET).
- Genomic study identifies link between Native American ancestry, relapse in young leukemia patients Sunday, February 6, 2011 @ 11:46PMThe first genome-wide study to demonstrate an inherited genetic basis for racial and ethnic disparities in cancer survival linked Native American ancestry with an increased risk of relapse in young leukemia patients. The work was done by investigators at St. Jude Children's Research Hospital and the Children's Oncology Group.
- TV highlights Feb. 5-6, 2011: Reagan centennial, post-Super Bowl 'Glee' Friday, February 4, 2011 @ 11:00PMOxygen starts airing "Glee" in reruns Saturday morning, beginning with a marathon of episodes that kicks off at 11 a.m. with the pilot.
- Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer Wednesday, February 2, 2011 @ 4:32AMInovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of Inovio's SynCon DNA vaccine for prostate cancer targeting two antigens.
- Both absence of insulin and resistance to insulin are associated with defects in FAS Friday, January 28, 2011 @ 10:48PMA key mechanism that appears to contribute to blood vessel damage in people with diabetes has been identified by researchers at Washington University School of Medicine in St. Louis.
- Magnetic nanoparticles for ovarian cancer treatment Friday, January 28, 2011 @ 1:07AMA paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option - one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.
- Chile Pepper Institute introduces 'NuMex Jalmundo' Tuesday, January 18, 2011 @ 10:53AMJalapeño fans take note -- a new, jumbo pepper is now available for your eating and cooking pleasure. The New Mexico State University chile pepper breeding program recently announced the release of a large-size jalapeño pepper dubbed 'NuMex Jalmundo'. According to Paul Bosland, Department of Plant and Environmental Sciences at NMSU and co-founder of the nonprofit Chile Pepper Institute, "the ...
- Genetic origin of cultivated citrus determined Tuesday, January 18, 2011 @ 10:52AMCitrus species are among the most important fruit trees in the world. Citrus has a long history of cultivation, often thought to be more than 4,000 years. Until now, however, the exact genetic origins of cultivated citrus such as sweet orange (Citrus sinensis), lemon (C. limon), and grapefruit (C. paradisi) have been a mystery. A team of researchers from China has published a study in the ...
- New Research Suggests Eating Vegetables Gives You A Healthier And More Attractive Glow Than A Suntan Thursday, January 13, 2011 @ 5:12AMNew research suggests eating vegetables gives you a healthy tan. The study, led by Dr Ian Stephen at The University of Nottingham, showed that eating a healthy diet rich in fruit and vegetables gives you a more healthy golden glow than the sun. The research, which showed that instead of heading for the sun the best way to look good is to munch on carrots and tomatoes, has been published in the ...
- Getting Tan From Greens Wednesday, January 12, 2011 @ 12:18AMNew research suggests eating vegetables gives you a healthy tan. The study, led by Dr Ian Stephen at The University of Nottingham, showed that eating a healthy diet rich in fruit and vegetables gives you a more healthy golden glow than the sun. The research, which showed that instead of heading for the sun the best way to look good is to munch on carrots and tomatoes, has been published in the ...
- Eating vegetables gives skin a more healthy glow than the sun, study shows Tuesday, January 11, 2011 @ 2:20PMNew research suggests eating vegetables gives you a healthy tan. The study showed that eating a healthy diet rich in fruit and vegetables gives you a more healthy golden glow than the sun.
- Looking good on greens Tuesday, January 11, 2011 @ 11:13AM( University of Nottingham ) New research suggests eating vegetables gives you a healthy tan. The study, led by Dr Ian Stephen at The University of Nottingham, showed that eating a healthy diet rich in fruit and vegetables gives you a more healthy golden glow than the sun.
- When it's cool, female butterflies chase males in sex role reversal Thursday, January 6, 2011 @ 1:31PMIf you want to be surrounded by females on the prowl, it pays to be cool, at least if you are a male butterfly.
- New research finds physicians not following standard care guidelines for OA Wednesday, January 5, 2011 @ 2:09AMNew research found clinicians who care for patients with osteoarthritis are likely not following standard care guidelines that are based on current medical evidence.
- FDA approves Novartis' Amturnide for treatment of high blood pressure Wednesday, December 22, 2010 @ 11:36PMToday Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
- Researchers receive $100,000 NFL grant for spinal injury tissue engineering research Wednesday, December 22, 2010 @ 4:06AMResearchers from Cornell University and Weill Cornell Medical College have been awarded $100,000 by NFL Charities, the charitable foundation of the National Football League owners, to research tissue engineering for spinal injuries.
- Studies Detail Triumphs, Troubles Of African Innovators Creating Products For Local Health Needs Tuesday, December 14, 2010 @ 11:18AMGlobal health experts have published a landmark collection of papers that together provide a unique microscope on the experience of countries, companies and organizations in sub-Saharan Africa addressing neglected health problems with homegrown drugs, vaccines, diagnostics and other creative scientific and business solutions. The first-of-its kind study chronicles the triumphs and troubles of ...
- Studies Detail Triumphs, Troubles Of African Innovators Creating Products For Local Health Needs Monday, December 13, 2010 @ 4:01PMAfricans strengthen ability to meet health needs in sub-Sahara with homegrown science solutions, but many products stagnate in labs for want of commercialization know-how, support Global health experts today published a landmark collection of papers that together provide a unique microscope on the experience of countries, companies and organizations in sub-Saharan Africa addressing neglected ...
- Gangster birds running protection racket give insight into coevolution Thursday, November 18, 2010 @ 6:22PMLike gangsters running a protection racket, drongos in the Kalahari Desert act as lookouts for other birds in order to steal a cut of their food catch. The behavior may represent a rare example of two species evolving from a parasitic to a mutualistic relationship.
- CDC data: Adults remain unvaccinated against preventable infectious illnesses Thursday, November 18, 2010 @ 4:39AMNew data from the Centers for Disease Control and Prevention (CDC) show that adults remain largely unvaccinated against preventable infectious illnesses.
- Report analyzes global PET SPECT Market Wednesday, November 10, 2010 @ 4:23AMThe report analyzes the PET SPECT Market by technologies and applications and studies the major market drivers, restraints, and opportunities for the PET SPECT market in U.S., EMEA, and Asia-Pacific.
- BioWatch: More than 800 expected at bio conference Friday, October 22, 2010 @ 3:40AMCEOs from two Maryland biotech heavyweights will be among the speakers headlining the sixth annual Mid-Atlantic Bio Conference, which kicks off with a reception Wednesday evening in North Bethesda.
- ACG meeting to exhibit Cimzia data for Crohn's disease treatment Monday, October 18, 2010 @ 2:20AMStudies and analyses of the Crohn's disease (CD) treatment Cimzia (certolizumab pegol) will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology, taking place in San Antonio from October 15 – 20.
